Retractable Technologies (RVP) Cash from Investing Activities (2010 - 2026)
Retractable Technologies (RVP) posted Cash from Investing Activities of $1.7 million for Q1 2026, up 1575.37% on a QoQ basis from -$114698.0 in Q4 2025, and up 122.01% year-over-year from $762239.0 in Q1 2025.
Retractable Technologies (RVP) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Retractable Technologies' Cash from Investing Activities history runs 17 years deep, the most recent figure standing at $1.7 million for Q1 2026.
- Quarterly Cash from Investing Activities rose 122.01% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.9 million (up 40.4% YoY) and the FY2025 annual result came in at $6.0 million, up 63.51% from the prior year.
- Cash from Investing Activities was $1.7 million for Q1 2026 at Retractable Technologies, up from -$114698.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $3.5 million in Q2 2025 and bottomed at -$17.6 million in Q2 2022.
- A 5-year average of -$1.8 million and a median of -$322324.0 in 2024 frame the typical range for Cash from Investing Activities.
- Peak annual rise in Cash from Investing Activities reached 1197.4% in 2025, while the deepest fall reached 107.35% in 2025.
- Retractable Technologies' Cash from Investing Activities stood at -$3.1 million in 2022, then surged by 88.6% to -$347758.0 in 2023, then surged by 548.55% to $1.6 million in 2024, then slumped by 107.35% to -$114698.0 in 2025, then soared by 1575.37% to $1.7 million in 2026.
- Business Quant data shows RVP's Cash from Investing Activities at $1.7 million in Q1 2026, -$114698.0 in Q4 2025, and $1.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | -218.00 Mn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | -96.00 Mn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | -58.03 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -77.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | -131.58 Mn |
| 10 | Retractable Technologies | 20.49 Mn | -15.13 Mn | -838,408.00 | 1.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.69 Mn |
| Mar 31, 2026 | 1.69 Mn |
| Dec 31, 2025 | -114,698.00 |
| Dec 31, 2025 | -114,698.00 |
| Sep 30, 2025 | 1.80 Mn |
| Sep 30, 2025 | 1.80 Mn |
| Jun 30, 2025 | 3.54 Mn |
| Jun 30, 2025 | 3.54 Mn |
| Mar 31, 2025 | 762,239.00 |
| Mar 31, 2025 | 762,239.00 |
| Dec 31, 2024 | 1.56 Mn |
| Dec 31, 2024 | 1.56 Mn |
| Sep 30, 2024 | 2.93 Mn |
| Sep 30, 2024 | 2.93 Mn |
| Jun 30, 2024 | -322,324.00 |
| Jun 30, 2024 | -322,324.00 |
| Mar 31, 2024 | -502,722.00 |
| Mar 31, 2024 | -502,722.00 |
| Dec 31, 2023 | -347,758.00 |
| Dec 31, 2023 | -347,758.00 |